• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session

    11/7/22 12:46:20 PM ET
    $ACMR
    $AFMD
    $AMBO
    $AMG
    Industrial Machinery/Components
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACMR alert in real time by email

    Gainers

    • Dragon Victory International Limited (NASDAQ:LYL) surged 52.2% to $0.6870.
    • Veru Inc. (NASDAQ:VERU) shares jumped 47% to $15.22 following publication of briefing documents ahead of the Nov. 9 FDA Adcom meeting for its COVID-19 treatment candidate.
    • Oyster Point Pharma, Inc. (NASDAQ:OYST) gained 39.4% to $11.64 after the company announced it will be acquired by Viatris for $11 per share.
    • GigaCloud Technology Inc. (NASDAQ:GCT) shares climbed 36.7% to $6.37. GigaCloud Technology, last month, unveiled its new private domain feature for sellers on its B2B GigaCloud Marketplace.
    • Selina Hospitality PLC (NASDAQ:SLNA) shares climbed 27.4% to $4.6001 after dipping over 19% on Friday.
    • ACM Research, Inc. (NASDAQ:ACMR) gained 24.2% to $8.21 after Jefferies upgraded the stock from Underperform to Hold.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) rose 24% to $1.9201. Sonnet BioTherapeutics recently announced the safety profile of SON-1010. Five of the six patients had stable disease at the first follow-up scan, with one patient progressing who is now off study.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) shares gained 23.9% to $21.65 amid recent reports suggesting Donald Trump could announce a 2024 presidential run this week. Digital World Acquisition Corp is the business combination partner of Trump Media & Technology Group.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 22% to $0.7079.
    • Certara, Inc. (NASDAQ:CERT) gained 20.5% to $12.83 after Arsenal Capital Partners increased its investment in the company with a $449 million stock purchase.
    • Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) surged 19.5% to $37.70 after the company reported better-than-expected Q3 results.
    • Tupperware Brands Corporation (NYSE:TUP) rose 17.5% to $4.7250. Richard Goudis, Executive Vice Chair at Tupperware Brands, reported a large insider buy on November 7, according to a new SEC filing.
    • Bon Natural Life Limited (NASDAQ:BON) gained 17.4% to $1.5620.
    • SmileDirectClub, Inc. (NASDAQ:SDC) gained 15.6% to $0.74.
    • HUTCHMED (China) Limited (NYSE:HCM) jumped 15.6% to $10.24.
    • Affimed N.V. (NASDAQ:AFMD) surged 15.5% to $2.2527. Affimed issued data update from two Phase 1/2a trials with innate cell engager AFM24 in solid tumor patients at 37th SITC Annual Meeting.
    • Viatris Inc (NASDAQ:VTRS) gained 15.3% to $11.19 after the company announced it will acquire Oyster Point Pharma.
    • Spirit AeroSystems Holdings, Inc. (NYSE:SPR) jumped 13.4% to $26.56 after Wolfe Research upgraded the stock from Underperform to Peer Perform. The company also announced a private offering of $800 million of senior secured first lien notes due 2029.
    • Triumph Bancorp, Inc. (NYSE:TBK) gained 11.7% to $55.12. Triumph Bancorp commenced a modified "Dutch Auction" tender offer to repurchase up to $100 million of its common stock.
    • Phunware, Inc. (NASDAQ:PHUN) shares rose 11.3% to $1.3350 following recent reports Donald Trump could soon announce a 2024 presidential run. The company was involved in the creation of the Trump 2020 mobile app.
    • Comstock Resources, Inc. (NYSE:CRK) rose 10.9% to $20.44. The company recently posted upbeat Q3 results.
    • Amarin Corporation plc (NASDAQ:AMRN) gained 10.7% to $1.2950. The company recently posted downbeat quarterly sales.
    • Affiliated Managers Group, Inc. (NYSE:AMG) surged 10.6% to $137.07 after the company reported better-than-expected Q3 EPS and sales results. The company also increased its buyback to a total of 5.8 million shares of common stock.
    • SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) rose 9.6% to $5.14 after gaining around 8% on Friday.
    • GDS Holdings Limited (NASDAQ:GDS) rose 9.5% to $10.49.
    • Millicom International Cellular S.A. (NASDAQ:TIGO) rose 9.2% to $12.89. Atlas Investissement confirmed that it acquired a 7% interest in Millicom.
    • Remark Holdings, Inc. (NASDAQ:MARK) rose 8.8% to $0.2905.


    Losers

    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) shares dipped 88.4% to $20.82 after the company reported pricing of $25 million registered direct offering.
    • Inhibikase Therapeutics, Inc. (NYSE:IKT) dropped 34% to $0.5093 after the company announced an FDA clinical hold on its IkT-148009 programs.
    • Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) dipped 28.6% to $0.6440.
    • Verve Therapeutics, Inc. (NASDAQ:VERV) fell 27.6% to $22.66 after the company reported its VERVE-101 IND application was placed on hold by the FDA. The company also reported Q3 earnings results.
    • Satixfy Communications Ltd. (NYSE:SATX) shares fell 24.7% to $9.56 after jumping 65% on Friday.
    • Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) dipped 19.6% to $2.6288.
    • Ritchie Bros. Auctioneers Incorporated (NYSE:RBA) dropped 19% to $50.44 after the company announced it will acquire IAA in a stock and cash transaction valued at roughly $7.3 billion.
    • First Watch Restaurant Group, Inc. (NASDAQ:FWRG) fell 18.4% to $13.20 after the company posted Q3 results.
    • WeTrade Group, Inc. (NASDAQ:WETG) dipped 16% to $1.2058.
    • Biora Therapeutics, Inc. (NASDAQ:BIOR) dipped 15.9% to $0.2763. Biora Therapeutics announced a $9.75 million direct offering.
    • Peak Bio, Inc. (NASDAQ:PKBO) fell 15% to $6.65. Ladenburg Thalmann recently initiated coverage on Peak Bio with a Buy rating and announced a price target of $15.
    • Carvana Co. (NYSE:CVNA) dipped 14.4% to $7.50 on continued weakness after the company reported worse-than-expected Q3 financial results last Thursday. The company reported a year-over-year decrease in both revenue and retail units sold.
    • LSB Industries, Inc. (NYSE:LXU) fell 14.4% to $14.20 after the company announced a secondary offering of 14.35 million shares of common stock by a selling stockholder with the company repurchasing 3.5 million of the shares.
    • Redfin Corporation (NASDAQ:RDFN) dropped 13.5% to $3.4750 after Oppenheimer downgraded the stock from Perform to Underperform.
    • Sentage Holdings Inc. (NASDAQ:SNTG) shares fell 13.5% to $3.54 after jumping 35% on Friday.
    • Ruth's Hospitality Group, Inc. (NASDAQ:RUTH) declined 12% to $16.68. Raymond James downgraded Ruth's Hospitality Group from Strong Buy to Market Perform.
    • Beam Therapeutics Inc. (NASDAQ:BEAM) dropped 11.3% to $37.96 after the company reported a wider Q3 loss.
    • HireRight Holdings Corporation (NYSE:HRT) dropped 11.3% to $7.08. HireRight Holdings recently reported worse-than-expected Q3 sales results.
    • Cepton, Inc. (NASDAQ:CPTN) dipped 11.2% to $1.98.
    • Quanergy Systems, Inc. (NYSE:QNGY) shares fell 7.5% to $0.7698. Quanergy Systems recently priced its $16.7 million offering.
    • Ambow Education Holding Ltd. (NYSE:AMBO) fell 7.3% to $0.3740 after jumping around 42% on Friday.
    • FAT Brands Inc. (NASDAQ:FAT) shares fell 5.1% to $7.31. FAT Brands announced withdrawal of proposed common stock offering.
    Get the next $ACMR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACMR
    $AFMD
    $AMBO
    $AMG

    CompanyDatePrice TargetRatingAnalyst
    Beam Therapeutics Inc.
    $BEAM
    2/20/2026$74.00Buy
    Canaccord Genuity
    Millicom International Cellular S.A.
    $TIGO
    2/11/2026$43.00Sector Perform → Sector Underperform
    Scotiabank
    Viatris Inc.
    $VTRS
    2/9/2026$18.00Neutral → Buy
    UBS
    Inhibikase Therapeutics Inc.
    $IKT
    1/21/2026$6.00Buy
    BofA Securities
    Viatris Inc.
    $VTRS
    1/16/2026$15.00Hold → Buy
    Argus
    Comstock Resources Inc.
    $CRK
    1/16/2026$24.00Buy → Neutral
    BofA Securities
    Millicom International Cellular S.A.
    $TIGO
    1/15/2026$70.00Neutral → Buy
    UBS
    Certara Inc.
    $CERT
    1/6/2026$13.00Market Perform → Outperform
    Leerink Partners
    More analyst ratings

    $ACMR
    $AFMD
    $AMBO
    $AMG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Beam Therapeutics with a new price target

    Canaccord Genuity initiated coverage of Beam Therapeutics with a rating of Buy and set a new price target of $74.00

    2/20/26 8:23:45 AM ET
    $BEAM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Millicom International Cellular downgraded by Scotiabank with a new price target

    Scotiabank downgraded Millicom International Cellular from Sector Perform to Sector Underperform and set a new price target of $43.00

    2/11/26 7:50:06 AM ET
    $TIGO
    Telecommunications Equipment
    Telecommunications

    Viatris upgraded by UBS with a new price target

    UBS upgraded Viatris from Neutral to Buy and set a new price target of $18.00

    2/9/26 6:59:24 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $AFMD
    $AMBO
    $AMG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ritchie Bros. Sells US$265+ Million in Orlando and Delivers Unmatched Scale at Industry's Largest Auction

    14,500+ assets sold as global event signals strong start to 2026 equipment market RB Global, Inc. (NYSE:RBA) (TSX:RBA), a trusted global marketplace for insights, services and transaction solutions for commercial assets and vehicles, today announced Ritchie Bros. Auctioneers generated more than US$265+ million in gross transaction value (GTV) during its Feb. 16-20 premier global auction in Orlando, FL, selling more than 14,500 equipment items, trucks and vehicles. The five-day auction drew more than 19,500 participants from 80+ countries across construction, transportation, agriculture and energy sectors. Approximately 86% of assets sold to U.S. buyers, including 39% purchased by Florid

    2/26/26 4:45:00 PM ET
    $RBA
    Real Estate

    First Watch Restaurant Group, Inc. to Participate in Three March Investor Conferences

    BRADENTON, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (NASDAQ:FWRG) ("First Watch" or the "Company"), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced that it will participate in three March investor conferences: The Company will meet with institutional investors at the 47th Annual Raymond James Institutional Investors Conference on Tuesday, March 3, 2026 in Orlando, Fla. and host a fireside chat at 3:25 PM ET.The Company will meet with institutional investors at the Citi 2026 Global Consumer & Retail Conference in Aventura, Fla. on Monday, March 9, 2026.The Company will meet with institutional investors at the Bank of

    2/26/26 8:00:00 AM ET
    $FWRG
    Restaurants
    Consumer Discretionary

    ACM Research Delivers Multiple Single-Wafer Cleaning Systems to Foundry Customer in Singapore

    -Represents ACM's First Delivery to Singapore-based Facility- FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- ACM Research, Inc. ("ACM") (NASDAQ:ACMR), a leading supplier of wafer and panel processing solutions for semiconductor and advanced packaging applications, announced the recent delivery of several 300mm single-wafer cleaning systems to a foundry customer's front-end wafer fabrication facility in Singapore. This marks ACM's first deployment to a Singapore-based fab and an important step in expanding ACM's presence in Southeast Asia as part of its global growth strategy. The systems support wafer backside cleaning and wet etch processes for advanced semiconductor manufacturi

    2/26/26 7:00:00 AM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    $ACMR
    $AFMD
    $AMBO
    $AMG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Sands Capital Life Sciences Pulse Fund Ii, L.P. bought $2,999,999 worth of shares (2,068,965 units at $1.45) (SEC Form 4)

    4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)

    11/24/25 3:47:02 PM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Kalin Katherine Bach bought $100,806 worth of shares (63,400 units at $1.59), increasing direct ownership by 155% to 104,400 units (SEC Form 4)

    4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)

    11/21/25 8:45:10 AM ET
    $SLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Stein Deborah bought $101,258 worth of shares (1,000 units at $101.26) (SEC Form 4)

    4 - RB GLOBAL INC. (0001046102) (Issuer)

    11/13/25 1:30:41 PM ET
    $RBA
    Real Estate

    $ACMR
    $AFMD
    $AMBO
    $AMG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TYRVAYA issued to OYSTER POINT PHARMA INC

    Submission status for OYSTER POINT PHARMA INC's drug TYRVAYA (ORIG-1) with active ingredient VARENICLINE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 213978, Application Classification: Type 3 - New Dosage Form

    10/19/21 7:27:01 PM ET
    $OYST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $AFMD
    $AMBO
    $AMG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President Ciaramella Giuseppe exercised 35,000 shares at a strike of $17.00 and sold $1,120,042 worth of shares (35,000 units at $32.00) (SEC Form 4)

    4 - Beam Therapeutics Inc. (0001745999) (Issuer)

    2/26/26 4:05:04 PM ET
    $BEAM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Aurentz Vincent returned 255,299 shares to the company, decreasing direct ownership by 33% to 510,596 units (SEC Form 4)

    4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)

    2/24/26 8:54:26 PM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President & Head of R&D Cabell Christopher returned 338,282 shares to the company, decreasing direct ownership by 33% to 676,564 units (SEC Form 4)

    4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)

    2/24/26 8:53:37 PM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACMR
    $AFMD
    $AMBO
    $AMG
    SEC Filings

    View All

    SEC Form 6-K filed by Millicom International Cellular S.A.

    6-K - MILLICOM INTERNATIONAL CELLULAR SA (0000912958) (Filer)

    2/26/26 4:31:03 PM ET
    $TIGO
    Telecommunications Equipment
    Telecommunications

    SEC Form 8-K filed by Affiliated Managers Group Inc.

    8-K - AFFILIATED MANAGERS GROUP, INC. (0001004434) (Filer)

    2/26/26 4:31:05 PM ET
    $AMG
    Investment Managers
    Finance

    SEC Form 10-K filed by Viatris Inc.

    10-K - Viatris Inc (0001792044) (Filer)

    2/26/26 4:26:46 PM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $AFMD
    $AMBO
    $AMG
    Leadership Updates

    Live Leadership Updates

    View All

    AMG Appoints G. Staley Cates to its Board of Directors

    Karen L. Alvingham to Retire from Board of Directors  WEST PALM BEACH, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) -- AMG, a strategic partner to leading independent investment management firms globally, today announced the appointment of G. Staley Cates to its Board of Directors (the "Board"), effective April 1, 2026; the Company also announced the forthcoming retirement of Karen L. Alvingham from the Board, effective April 1, 2026. Lady Alvingham was appointed to AMG's Board of Directors in January 2018. Mr. Cates served as the Vice Chairman of Southeastern Asset Management, Inc. ("Southeastern"), an independent global investment management firm, from 2015 through 2024, having served as Presi

    2/26/26 6:59:00 AM ET
    $AMG
    Investment Managers
    Finance

    Viatris Appoints Matthew J. Maletta as Chief Legal Officer

    Brian Roman to Leave the Company After More Than 20 Years of Exemplary Service; Will Remain Advisor Through Transition Period  PITTSBURGH, Feb. 3, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS) announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective February 9, 2026. The appointment follows the transition of the Company's current CLO, Brian Roman, after more than 20 years of exemplary service to Viatris and its predecessor company, Mylan. Roman, who has served in multiple leadership positions and played a key role in supporting the Company's operations, portfolio and growth initiatives, will stay on through April 1, 2026, to ensure a smooth transition

    2/3/26 8:30:00 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer

    PITTSBURGH, Jan. 8, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS) announced today that Lara Ramsburg has been appointed Chief People and Corporate Affairs Officer. As part of Viatris' ongoing transformation efforts, this newly combined role is designed to continue to advance the company's culture and connectivity across the globe, while also strengthening the alignment of the organization's internal and external stakeholder communication strategies. Ramsburg is an accomplished leader with more than 25 years of experience building and leading highly effective cross-functional

    1/8/26 9:05:00 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $AFMD
    $AMBO
    $AMG
    Financials

    Live finance-specific insights

    View All

    Ritchie Bros. Sells US$265+ Million in Orlando and Delivers Unmatched Scale at Industry's Largest Auction

    14,500+ assets sold as global event signals strong start to 2026 equipment market RB Global, Inc. (NYSE:RBA) (TSX:RBA), a trusted global marketplace for insights, services and transaction solutions for commercial assets and vehicles, today announced Ritchie Bros. Auctioneers generated more than US$265+ million in gross transaction value (GTV) during its Feb. 16-20 premier global auction in Orlando, FL, selling more than 14,500 equipment items, trucks and vehicles. The five-day auction drew more than 19,500 participants from 80+ countries across construction, transportation, agriculture and energy sectors. Approximately 86% of assets sold to U.S. buyers, including 39% purchased by Florid

    2/26/26 4:45:00 PM ET
    $RBA
    Real Estate

    ACM Research Reports Fourth Quarter and Fiscal Year 2025 Results

    FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- ACM Research, Inc. ("ACM") (NASDAQ:ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced packaging applications, today reported financial results for its fourth quarter and fiscal year ended December 31, 2025. "2025 was a year of strong execution for ACM," said ACM's President and Chief Executive Officer, Dr. David Wang. "We delivered record annual revenue of $901 million, up 15% year over year, outperforming estimated China WFE. We strengthened our foundation for long-term growth by advancing new products, expanding our global production capacity, and enhancing global funding initiatives." Dr. Wang conti

    2/26/26 7:00:00 AM ET
    $ACMR
    Industrial Machinery/Components
    Technology

    Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results

    Reports Fourth-Quarter Total Revenues of $3.7B and Full-Year 2025 Total Revenues of $14.3BMeets or Exceeds 2025 Financial Guidance Across All Key Metrics[1]Returns More Than $1B to Shareholders in 2025; Expects Balanced Capital Allocation Approach for 2026Provides 2026 Financial Guidance; Positioned for Sustainable GrowthAnticipates Regulatory Decisions for Six Product Candidates in 2026 and Multiple Important Pipeline MilestonesCompletes Enterprise-Wide Strategic Review; Expects to Deliver $650M in Total Cost Savings With Reinvestment of up to $250M Over the Next 3 YearsPITTSBURGH, Feb. 26, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS) today announced robust financial results for the four

    2/26/26 6:59:00 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACMR
    $AFMD
    $AMBO
    $AMG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13G filed by Verve Therapeutics Inc.

    SC 13G - Verve Therapeutics, Inc. (0001840574) (Subject)

    11/18/24 5:23:52 PM ET
    $VERV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Carvana Co.

    SC 13G/A - CARVANA CO. (0001690820) (Subject)

    11/14/24 5:58:14 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary